Paper Details

  1. Home
  2. Paper Details

Combined diosmectite and mesalazine treatment for mild-to-moderate ulcerative colitis: a randomized, placebo-controlled study.

Author: CuiHui-Fei, JiangXue-Liang, WangHua-Hong

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This study found that combined diosmectite and mesalazine treatment successfully induced and maintained the treatment of active mild-to-moderate ulcerative colitis (UC). The Diosmectite group had a significantly higher clinical remission rate and mucosal healing rate compared to the Placebo group at both 8 weeks and 52 weeks.
Paper Details　
Original Abstract of the Article :
BACKGROUND: The relapse rate of ulcerative colitis (UC) is high. The efficacy of combined diosmectite and mesalazine treatment for active mild-to-moderate UC was investigated. MATERIAL/METHODS: A total of 120 patients with UC were enrolled in this randomized, single-blind, placebo-controlled study....See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301466/

データ提供：米国国立医学図書館（NLM）

Diosmectite and Mesalazine: A Collaborative Approach to Ulcerative Colitis

The [management of ulcerative colitis (UC)] is a complex and challenging endeavor. This study explores the efficacy of a [combined diosmectite and mesalazine treatment] for [active mild-to-moderate UC]. The researchers conducted a [randomized, placebo-controlled study] to compare the effectiveness of this combination therapy with a [placebo and mesalazine] control group. Their findings revealed that the [combined diosmectite and mesalazine treatment] achieved significantly higher rates of [clinical remission and mucosal healing] compared to the control group. The study provides encouraging evidence for the potential of this combination therapy to effectively manage [mild-to-moderate UC].

Positive Outcomes for Ulcerative Colitis Treatment

The study’s results demonstrate the potential of [diosmectite and mesalazine] to significantly improve [clinical remission and mucosal healing] rates in patients with [mild-to-moderate UC]. The observed higher remission rates in the treatment group suggest that this combination therapy could be a valuable option for managing this chronic inflammatory bowel disease.

Empowering Patients with Ulcerative Colitis

This research provides hope for [patients with ulcerative colitis], offering a potential new approach to managing their symptoms. The study’s findings highlight the importance of [exploring different treatment options] and working with healthcare professionals to develop a personalized treatment plan. By understanding the [efficacy of various medications], individuals can make informed decisions and potentially achieve improved health outcomes.

Dr.Camel's Conclusion

Like a camel carrying precious cargo across the desert, this study delivers valuable insights into the treatment of ulcerative colitis. The findings highlight the potential of diosmectite and mesalazine to effectively manage symptoms and improve quality of life for patients, offering a hopeful beacon amidst the challenges of this chronic disease.

Date :
  1. Date Completed 2015-10-27
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

25582578

DOI: Digital Object Identifier

PMC4301466

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.